Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.

We compared the pharmacodynamics and killing activity of ceftazidime, administered by continuous infusion and intermittent bolus, against Pseudomonas aeruginosa ATCC 27853 and ceftazidime-resistant P. aeruginosa 27853CR with and without a single daily dose of amikacin in an in vitro infection model...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Cappelletty, D M, Kang, S L, Palmer, S M, Rybak, M J
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1995
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162828/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486921/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1797
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!